unknown
Stage
About
Edinburgh Molecular Imaging (EM Imaging) is a clinical-stage biotechnology spin-out from the University of Edinburgh developing a C-Met molecular targeting technology platform. The company is developing a radiotherapeutic agent for cancer treatment alongside a fluorescent optical imaging agent.
Explore Edinburgh Molecular Imaging's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.